HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...

Dear D.J.: The initial treatment for OAB symptoms usually consists of lifestyle changes (i.e., quitting smoking, avoiding medications that worsen symptoms and excess fluid intake at night), pelvic ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved ...

HYDERABAD, India, Jul 12, 2013 (BUSINESS WIRE) -- Dr. Reddy's Laboratories RDY +2.67% announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of ...

https://www.thehindubusinessline.com/companies/dr-reddys-gets-approval-for-generic-semaglutide-injection-in-canada/article70919146.ece Copy Dr. Reddy’s Laboratories ...